Takahiro Shimo

Mr. Takahiro Shimo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2024 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Verified
Journal Article
Closed access
SSShunsuke Suzuki
Shunsuke Suzuki
TYTakayuki Yagihashi
Takayuki Yagihashi
KNKazunori Nitta
Kazunori Nitta
MYMasashi Yamanaka
Masashi Yamanaka
TSTakahiro Shimo
Takahiro Shimo
HTHiroki Tanaka
Hiroki Tanaka

1 January 2025 in Journal of Medical Physics
Verified
Journal Article
Open access
TSTakahiro Shimo
Takahiro Shimo
SSShintaro Shiba
Shintaro Shiba
HWHiroyuki Watanabe
Hiroyuki Watanabe
MYMasashi Yamanaka
Masashi Yamanaka
KMKazuki Matsumoto
Kazuki Matsumoto
KTKohichi Tokuuye
Kohichi Tokuuye
Purpose: This study evaluated whether the mini-ridge filter (MRF) used for beam energy optimization in a synchrotron-based proton beam therapy (PBT) affects the generation of secondary neutrons and photons. Materials and Methods: Secondary radiation from the PBT was evaluated using a Monte Carlo simulation (MCS) with the Particle and Heavy-ion Transport code System (version 3.31), and the PROBEAT-M1 system (Hitachi, Japan) was modeled. In the analysis, we focused on the production of neutrons and photons in a 35 cm ×35 cm ×35 cm water phantom with and without MRF to ensure the accuracy of the dose calculation. Results: The MCS results were in good agreement with the measurement results, and the off-axis ratio at the center of the spread-out Bragg peak was 100% at a gamma analysis pass rate of 2 mm/2%. The photon fluence decreased by 4.0 and 0.9% at 70.2 and 228.7 MeV, respectively, but no significant effect on total neutron and photon production was observed (P > 0.05). The MRF effect on the dose was <0.11 μGy Gy−1, suggesting that a clinically significant effect is negligible. Conclusions: These results demonstrated that MRF had a limited effect on the generation of secondary radiation in PBT. MRF, which is used to improve dose distribution, has the potential to be safely used without increasing secondary radiation, and MRF might not affected to generate secondary radiation to clinically meaningful levels.

19 July 2022 in Archives of Breast Cancer
Verified
Journal Article
Open access
PDF file
KSKazuhiko Sato
Kazuhiko Sato
TSTakahiro Shimo
Takahiro Shimo
NNNana Natsume
Nana Natsume
NTNaoko Takeda
Naoko Takeda
HFHiromi Fuchikami
Hiromi Fuchikami
TOTomohiko Okawa
Tomohiko Okawa
Background: In partial-breast irradiation (PBI), the accurate target volume delineation based on the lumpectomy cavity (LC) remained difficult due to uncertain LC identification. However, the impact of accurate LC delineation on the planning target volume (PTV) has not been investigated. Materials and Methods: Between September 2018 and April 2020, 159 patients receiving perioperative PBI with multicather-interstitial brachytherapy have been evaluated. While LC delineated using implanted catheters as fiducial markers was used as a reference, conventional LC was virtually delineated on computed tomography with clips. PTV1-cm margin and PTV2-cm margin, which means 1cm and 2cm expansion from LC, were developed and assumed for brachytherapy and external-beam PBI, respectively. The target accuracy and the impact of the delineation accuracy of LC on PTVs were evaluated. The geographic miss index (GMI) and normal tissue index (NTI) were used as accuracy indices and were defined as the percentage of under- and overestimating volume, respectively. Results: The PTV1-cm margin and PTV2-cm margin were significantly larger than the reference volume, 57.9cm3 vs. 37.9cm3 (P<0.001) and 113.2cm3 vs. 93.8cm3 (P<0.001), respectively. The GMI and NTI of LC were 27.3% and 41.2%, respectively. Although the GMI in the PTV1-cm margin and PTV2-cm margin was significantly reduced to 9.8% (P<0.0001) and 9.9% (P<0.0001), respectively, the NTI was not significantly improved in the PTV1-cm margin, which was 41.8% (P=0.60) but was improved in PTV2-cm margin, which was 23.1% (P<0.0001). Conclusion: The GMI in PTV1-cm margin was reduced to be as low as PTV2-cm margin. Although PTV2-cm margin was associated with lower NTI, the absolute volume was almost double with PTV1-cm margin. Although further research was required, brachytherapy-based PBI may be a reasonable option to achieve tumor control and cosmesis using conventional delineation method.

22 March 2026 in Physica Medica
Verified
Journal Article
Closed access
MYMasashi Yamanaka
Masashi Yamanaka
KMKazuki Matsumoto
Kazuki Matsumoto
AYAkihiro Yamano
Akihiro Yamano
KNKazunori Nitta
Kazunori Nitta
RSRyosuke Shirata
Ryosuke Shirata
YMYutaro Mori
Yutaro Mori

17 June 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
TSTakahiro Shimo
Takahiro Shimo
SSShintaro Shiba
Shintaro Shiba
HWHiroyuki Watanabe
Hiroyuki Watanabe
MYMasashi Yamanaka
Masashi Yamanaka
KMKazuki Matsumoto
Kazuki Matsumoto
KTKohichi Tokuuye
Kohichi Tokuuye
This study aimed to investigate the distribution of thermal neutron fluence generated during proton-beam therapy (PBT) scanning, focusing on neutrons produced within the body using Monte Carlo simulations (MCSs). MCSs used the Particle and Heavy Ion Treatment Code System to define a 35 × 35 × 35 cm3 water phantom, and proton-beam energies ranging from 70.2 to 228.7 MeV were investigated. The MCS results were compared with neutron fluence measurements obtained from gold activation analysis, showing good agreement with a difference of 3.54%. The internal thermal neutron distribution generated by PBT was isotropic around the proton-beam axis, with the Bragg peak depth varying between 3.45 and 31.9 cm, while the thermal neutron peak depth ranged from 5.41 to 15.9 cm. Thermal neutron generation depended on proton-beam energy, irradiated particle count, and depth. Particularly, the peak of the thermal neutron fluence did not occur within the treatment target volume but in a location outside the target, closer to the source. This discrepancy between the Bragg peak and the thermal neutron fluence peak is a key finding of this study. These data are crucial for optimizing beam angles to maximize dose enhancement within the target during clinical applications of neutron capture-enhanced particle therapy.

29 December 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
AYAkihiro Yamano
Akihiro Yamano
TITatsuya Inoue
Tatsuya Inoue
RSRyosuke Shirata
Ryosuke Shirata
MYMasashi Yamanaka
Masashi Yamanaka
TYTakayuki Yagihashi
Takayuki Yagihashi
WCWeishan Chang
Weishan Chang
Background and purpose: Proton stereotactic body radiotherapy (SBRT) offers superior dose conformity. However, its clinical application remains limited due to uncertainties from setup errors and respiratory motion. This study quantified the dosimetric robustness of proton SBRT for early‐stage non‐small cell lung cancer under combined setup and interplay uncertainties and investigated the association between dosimetric robustness and case‐specific characteristics. Methods: Robust proton SBRT plans were generated considering setup and range uncertainties. Dosimetric robustness was evaluated by comparing the clinical target volume (CTV) coverage indices (V95%, V98%, and V100%) between the nominal condition and conditions incorporating combined setup and interplay uncertainties. The influence of respiratory amplitude, tumor volume, and mean tumor CT value on dosimetric robustness was assessed. Results: CTV coverage remained stable under nominal conditions. However, dose degradation occurred under combined setup and interplay uncertainties, with the median CTV V100% decreased below 70%. Larger respiratory amplitudes and lower mean tumor CT values were associated with reduced dosimetric robustness. Conclusions: Combined uncertainties significantly affected the dosimetric robustness of proton SBRT depending on case‐specific characteristics. Our exploratory analysis indicates the potential need for individualized robustness strategies in proton SBRT planning.